Vulvar cancer laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} {{AE}} {{sali}} | |||
{{Vulvar cancer}} | {{Vulvar cancer}} | ||
[[Human papilloma virus]] may be reported positive<ref name="pmid24505474">{{cite journal |vauthors=Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK |title=Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance |journal=PLoS ONE |volume=9 |issue=2 |pages=e88323 |date=2014 |pmid=24505474 |pmc=3914976 |doi=10.1371/journal.pone.0088323 |url=}}</ref>. | [[Human papilloma virus]] may be reported positive<ref name="pmid24505474">{{cite journal |vauthors=Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK |title=Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance |journal=PLoS ONE |volume=9 |issue=2 |pages=e88323 |date=2014 |pmid=24505474 |pmc=3914976 |doi=10.1371/journal.pone.0088323 |url=}}</ref>. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 14:11, 22 May 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]
|
Vulvar cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vulvar cancer laboratory findings On the Web |
|
American Roentgen Ray Society Images of Vulvar cancer laboratory findings |
|
Risk calculators and risk factors for Vulvar cancer laboratory findings |
Human papilloma virus may be reported positive[1].
References
- ↑ Nygård M, Hansen BT, Dillner J, Munk C, Oddsson K, Tryggvadottir L, Hortlund M, Liaw KL, Dasbach EJ, Kjær SK (2014). "Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance". PLoS ONE. 9 (2): e88323. doi:10.1371/journal.pone.0088323. PMC 3914976. PMID 24505474.